2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
Pyzer A, Dillon L, Sharon E, Karrison T, Zha Y, Fulton N, Gui G, Andrew G, Streicher H, Sweet K, Yaghmour G, Liu J, Jonas B, Schimmer A, Grant S, Zeidan A, Hildebrandt G, Lowrey C, Mattison R, Palmisiano N, Salhotra A, Tzachanis D, Baer M, Lin T, Patel P, Chen H, Stadler W, Odenike O, Larson R, Gajewski T, Hourigan C, Stock W, Liu H. Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia. Blood Advances 2025, 9: 2144-2152. PMID: 39928953, PMCID: PMC12051614, DOI: 10.1182/bloodadvances.2024015176.Peer-Reviewed Original ResearchRandomized phase II studyProgression-free survivalPhase II studyNivolumab armAdverse eventsObservation armOverall survivalII studyMedian duration of follow-upProgression-free survival curvesDuration of follow-upEfficacy of nivolumabIncomplete hematologic recoverySingle-agent nivolumabEvaluation of adverse eventsAcute myeloid leukemiaIncreased AEsAML chemotherapyMedian OSNivolumab administrationNivolumab maintenanceHematologic recoveryDisease relapseOpen-labelMedian duration
2017
Cost effectiveness of maintenance bevacizumab in patients with metastatic colorectal cancer.
Lange J, Rajeev R, Gamblin T, Turaga K. Cost effectiveness of maintenance bevacizumab in patients with metastatic colorectal cancer. Journal Of Clinical Oncology 2017, 35: 718-718. DOI: 10.1200/jco.2017.35.4_suppl.718.Peer-Reviewed Original ResearchQuality adjusted life monthsMetastatic colorectal cancerMaintenance capecitabineLife monthsColorectal cancerUnresectable metastatic colorectal cancerTreatment of unresectable metastatic colorectal cancerImproved overall survivalIncremental cost-effectiveness ratioQuality of Life ScaleCost-effectiveness ratioMaintenance bevacizumabObservation armOverall survivalLife ScaleBevacizumabMaintenance armGlobal quality of life scaleTreatment strategiesCapecitabinePatientsCost-effectiveCancerEffectiveness ratioMonths
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply